" Mr. Hayes, along with Pricewaterhouse Coopers agreed to restructure the Company together in May 2012. With the amicable cooperation of Company management at the time, the parties executed a Definitive Restructuring Agreement and plan in June 2012. This plan was presented to shareholders for a Special Meeting and vote to approve a 10:1 reverse split so the Company could be successfully reorganized into a medical device manufacturer, while hopefully providing a way for long-time shareholders of both the Company and NIR to potentially benefit and recoup some or more of their previous losses. Mr. Hayes agreed to contribute the assets of his privately held medical device company and Pricewaterhouse Coopers agreed to convert 100% of the Company's debt to NIR Funds, to equity in the newly restructured company. "
All the shares were outstanding before the restructure, there was nothing to liquidate. PwC created the shares they control via the restructure. They should have thrown the whole file in the dumpster, but agreed to the restructure. They are just as involved as Hayes at this point, because they helped and agreed to create the shares.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.